Duopharma Biotech Bhd (7148) - Total Liabilities
Based on the latest financial reports, Duopharma Biotech Bhd (7148) has total liabilities worth RM690.68 Million MYR (≈ $173.41 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore 7148 net asset momentum to track the company's year-over-year net asset growth rate.
Duopharma Biotech Bhd - Total Liabilities Trend (2006–2025)
This chart illustrates how Duopharma Biotech Bhd's total liabilities have evolved over time, based on quarterly financial data.
Duopharma Biotech Bhd Competitors by Total Liabilities
The table below lists competitors of Duopharma Biotech Bhd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
FS Bancorp Inc
NASDAQ:FSBW
|
USA | $2.89 Billion |
|
Berjaya Land Bhd
KLSE:4219
|
Malaysia | RM11.44 Billion |
|
Empresas Tricot S.A
SN:TRICOT
|
Chile | CL$219.18 Billion |
|
Armata Pharmaceuticals Inc
NYSE MKT:ARMP
|
USA | $295.48 Million |
|
Citizens Financial Services Inc. Common Stock
NASDAQ:CZFS
|
USA | $2.68 Billion |
|
Nak Sealing Technologies Corp
TW:9942
|
Taiwan | NT$1.30 Billion |
|
Shandong Swan Cotton
SHG:603029
|
China | CN¥1.40 Billion |
|
HansBiomed Corporation
KQ:042520
|
Korea | ₩92.52 Billion |
Liability Composition Analysis (2006–2025)
This chart breaks down Duopharma Biotech Bhd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see 7148 market cap overview.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.61 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | 0.93 | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.91 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.48 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Duopharma Biotech Bhd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Duopharma Biotech Bhd (2006–2025)
The table below shows the annual total liabilities of Duopharma Biotech Bhd from 2006 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | RM690.68 Million ≈ $173.41 Million |
+3.42% |
| 2024-12-31 | RM667.85 Million ≈ $167.67 Million |
+1.49% |
| 2023-12-31 | RM658.01 Million ≈ $165.21 Million |
+16.11% |
| 2022-12-31 | RM566.70 Million ≈ $142.28 Million |
+4.92% |
| 2021-12-31 | RM540.13 Million ≈ $135.61 Million |
+30.27% |
| 2020-12-31 | RM414.61 Million ≈ $104.10 Million |
+6.30% |
| 2019-12-31 | RM390.05 Million ≈ $97.93 Million |
+9.77% |
| 2018-12-31 | RM355.34 Million ≈ $89.21 Million |
+57.66% |
| 2017-12-31 | RM225.38 Million ≈ $56.58 Million |
+8.90% |
| 2016-12-31 | RM206.95 Million ≈ $51.96 Million |
+12.64% |
| 2015-12-31 | RM183.73 Million ≈ $46.13 Million |
+536.91% |
| 2014-12-31 | RM28.85 Million ≈ $7.24 Million |
+25.41% |
| 2013-12-31 | RM23.00 Million ≈ $5.78 Million |
-16.43% |
| 2012-12-31 | RM27.53 Million ≈ $6.91 Million |
-16.77% |
| 2011-12-31 | RM33.08 Million ≈ $8.30 Million |
-14.34% |
| 2010-12-31 | RM38.61 Million ≈ $9.69 Million |
+26.07% |
| 2009-12-31 | RM30.63 Million ≈ $7.69 Million |
+54.46% |
| 2008-12-31 | RM19.83 Million ≈ $4.98 Million |
+51.11% |
| 2007-12-31 | RM13.12 Million ≈ $3.29 Million |
-3.36% |
| 2006-12-31 | RM13.58 Million ≈ $3.41 Million |
-- |
About Duopharma Biotech Bhd
Duopharma Biotech Berhad, an investment holding company, researches, develops, manufactures, distributes, and imports pharmaceutical products and medicines in Malaysia and internationally. The company offers consumer healthcare products, such as vitamins, minerals, and supplements, analgesics, eyecare, antacids, and skin care products; and generic drugs for various therapeutic classes, such as ca… Read more